The circulatory half-lives of α -profibrin and α-fibrin monomer, and comparisons with other fibrin(ogen) derivatives

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Thrombosis and Haemostasis

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1055/s-0037-1613542
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibrin precursors, intermediaries for hemostasis in the clot war.

  2002cited by this paper
• Allosteric Effects Potentiating the Release of the Second Fibrinopeptide A from Fibrinogen by Thrombin*

  2002cited by this paper
• Crystal structure of native chicken fibrinogen at 2.7 A resolution.

  2001cited by this paper
• The Fibrin Intermediate, Its Place in the Fibrinogen‐Fibrin Transformation

  2001influential reference
• The Use of Soluble Fibrin in Evaluating the Acute and Chronic Hypercoagulable State

  1999cited by this paper
• Isolation and Characterization of the Fibrin Intermediate Arising from Cleavage of One Fibrinopeptide A from Fibrinogen*

  1996cited by this paper
• Soluble fibrin as a molecular marker for a pre-thrombotic state: a mini-review.

  1993cited by this paper
• GPR-phoresis, a novel approach to determining fibrin monomer and other macromolecular derivatives of fibrinogen and fibrin in blood.

  1993cited by this paper
• Effects of cross-linking on clearance of circulating alpha-fibrin monomer and its complexes.

  1990cited by this paper
• Characterization of a Mode of Specific Binding of Fibrin Monomer through its Amino-Terminal Domain by Macrophages and Macrophage Cell-Lines

  1990cited by this paper
• Survival of fibrinogen degradation products in the circulation after thrombolytic therapy for acute myocardial infarction

  1987cited by this paper
• Characterization of murine peritoneal macrophage receptors for fibrin(ogen) degradation products.

  1986cited by this paper
• Kinetic characterization of a saturable pathway for rapid clearance of circulating fibrin monomer.

  1985influential reference
• The role of ligand-ligand interactions in competition by fibrinogen and fibrin degradation products for fibrinogen binding to human platelets.

  1983cited by this paper
• The Clearance of Human Fibrinogen Fragments X and Y in Mice: A Process Mediated by the Fragment D Receptor

  1983cited by this paper
• The clearance of human fibrinogen fragments D1, D2, D3 and fibrin fragment D1 dimer in mice.

  1982cited by this paper
• Adsorptive endocytosis of fibrin monomer by macrophages: evidence of a receptor for the amino terminus of the fibrin alpha chain.

  1982cited by this paper
• Binding phenomena of isolated unique plasmic degradation products of human cross-linked fibrin.

  1979cited by this paper
• The in vivo behavior of the terminal derivatives of fibrinogen and fibrin cleaved by plasmin.

  1974cited by this paper
• The effect of fibrin-stabilizing factor on the subunit structure of human fibrin.

  1971cited by this paper
• SIGNIFICANCE OF CRYOPROFIBRIN IN FIBRINOGEN-FIBRIN CONVERSION

  1962cited by this paper
• Cofibrins and Fibrin‐Intermediates as Indicators of Thrombin Activity in Vivo

  1960cited by this paper

• Severe venom-induced consumption coagulopathy, snakebite-associated thrombotic microangiopathy, and local necrosis following Western Bush Viper (Atheris chlorechis) envenoming in France.

  2026cites this paper
• Serial fibrin monomer and D-dimer plasma levels measurements can capture thrombotic complications in critically ill COVID-19 patients: A prospective observational study

  2022cites this paper
• Sepsis-associated coagulopathy in onco-hematology patients presenting with thrombocytopenia: a multicentric observational study

  2022cites this paper
• Uninterrupted Dabigatran Administration Provides Greater Inhibition against Intracardiac Activation of Hemostasis as Compared to Vitamin K Antagonists during Cryoballoon Catheter Ablation of Atrial Fibrillation

  2020cites this paper
• Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature review.

  2018cites this paper
• disease Cause-effect relation between hyperfibrinogenemia and vascular

  2013cites this paper
• The acute effect of cigarette smoking on the high-sensitivity CRP and fibrinogen biomarkers in chronic obstructive pulmonary disease patients.

  2013cites this paper
• Evaluation of hypercoagulability using soluble fibrin monomer complex in sick newborns

  2013cites this paper
• Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis.

  2007cites this paper
• Cause-effect relation between hyperfibrinogenemia and vascular disease.

  2004cites this paper
• Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score

  2004cites this paper